Nexalin Technology Inc. (NXL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.83M
Last updated: Nov 17, 2026 at 11:04 AM ET
Nexalin Technology Inc. (NXL) Stock Forecast
Analysts expect Nexalin Technology (NXL) to earn -$11.42 per share in the fiscal year ending Dec 31, 2026, on revenue of $192000. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$7.55.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 76.0%.
- Fiscal year ending Dec 31, 2026
- -$11.42
- EPS consensus, revenue $192000
- Fiscal year ending Dec 31, 2027
- -$7.55
- EPS consensus, revenue $338000
- Next report
- Mar 23, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$11.42 | -$11.42 to -$11.42 | 1 | $192000 | $192000 to $192000 | 1 |
| Dec 31, 2027 | -$7.55 | -$7.55 to -$7.55 | 1 | $338000 | $338000 to $338000 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.36 | N/A | 2 | $90900 | $88200 to $94500 | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$11.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$11.42 | -$11.40 | -$11.40 | -$11.40 | -$11.40 | N/A |
| Fiscal year ending Dec 31, 2027 | -$7.55 | -$9.30 | -$9.30 | -$9.30 | -$9.30 | N/A |
Frequently Asked Questions About NXL
What is the NXL stock forecast?
Consensus analyst estimates put Nexalin Technology's EPS at -$11.42 for the fiscal year ending Dec 31, 2026, on revenue of $192000.
What EPS do analysts expect from NXL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$11.42, with estimates from -$11.42 to -$11.42 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$7.55, with estimates from -$7.55 to -$7.55 from 1 analyst.
What revenue do analysts expect from Nexalin Technology next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $192000, with estimates from $192000 to $192000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $338000, with estimates from $338000 to $338000.
How many analysts cover NXL?
1 analyst estimates EPS for Nexalin Technology for the fiscal year ending Dec 31, 2026.
NXL pages: Overview, Earnings, Forecast, Financials, Competitors